Article Details

Akebia Therapeutics (NASDAQ:AKBA) Rating Lowered to Sell at BidaskClub

Retrieved on: 2019-09-11 19:48:45

Tags for this article:

Click the tags to see associated articles and topics

Akebia Therapeutics (NASDAQ:AKBA) Rating Lowered to Sell at BidaskClub. View article details on hiswai:

Excerpt

<div><b>Man Group plc</b> raised its position in Akebia Therapeutics by 58.8% during the second quarter. <b>Man Group plc</b> now owns 934,650 shares of the ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up